Check out upcoming Advanced Hazmat Life Support Courses: https://www.clintox.org/ahls

Loading Events

Details

AACT Section Webinar: Trainee and Student

Register Now!


💻 Format: Virtual
💰 Cost: Free for AACT members | $20 for non-members

 

Title:
To Dialyze or Not to Dialyze: The SILENT Dilemma of Lithium Toxicity

Description:
Syndrome of Irreversible Lithium-Effectuated Neurotoxicity (SILENT) is a rare and poorly understood complication of lithium toxicity, defined by the persistence of neurologic sequelae for more than two months after discontinuation of lithium. While aggressive and rapid lithium removal with dialysis has been proposed as a strategy to prevent SILENT, evidence is mixed and may even caution against over-utilization of rapid elimination methods. This presentation aims to review the current literature on SILENT and the long-term neurologic effects of lithium toxicity, as well as review proposed strategies to mitigate its risk, with particular emphasis on the role of dialysis.

Presenter:
Tiana Patriarca, PharmD
Alabama Poison Information Center

Moderators:
Monica Thacker, MD
Harvard Medical School/Boston Children’s Hospital

Michael Keenan, MD
SUNY Upstate Medical University; Upstate Poison Center


Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Amedco LLCand American Academy of Clinical Toxicology. Amedco LLC is jointly accredited by the AccreditationCouncil for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education(ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education forthe healthcare team.

Amedco Joint Accreditation Provider Number: 4008163

Professions in scope for this activity are listed below.

Physicians
Amedco LLC designates this live activity for a maximum of 1 AMA PRA Category 1 Credits for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacists & Pharmacy Technicians
Amedco LLC designates this activity for a maximum of 1 knowledge-based CPE contact hours.
JA4008163-9999-26-114-L01-P | UAN JA4008163-9999-26-114-L01-T

NOTE to Pharmacists:
The only offi cial Statement of Credit is the one you pull from CPE Monitor. You must request yourcertifi cate within 45 days of your participation in the activity to meet the deadline for submission to CPE Monitor. Credits aregenerally reported during the fi rst week of each month for those who claimed during the month prior.